EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repeated TRPA1 Blockade Reduces Nociception and Neuroinflammation in a Relapsing–Remitting Mouse Model of Multiple Sclerosis

Ana Clara Machado Luiz, Diulle Spat Peres, Sabrina Qader Kudsi, Ricardo Iuri Felix Moraes iD, Caren Antoniazzi iD, Leonardo Gomes Pereira, Helen Alves Brito iD, Micheli Mainardi Pillat, Mariana Martins Flores, Patrícia Rodrigues iD, Gabriela Trevisan iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ana Clara Machado Luiz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Santa Maria 97105-900, Brazil. Hauptthemen laut MEDLINE: TRPA1 Cation Channel, Nociception, Encephalomyelitis, Autoimmune, Experimental, Neuroinflammatory Diseases. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relapsing–remitting multiple sclerosis (RRMS) is a chronic autoimmune and neurodegenerative disease characterized by neuroinflammation and demyelination. Neuropathic pain is a frequent and poorly managed symptom associated with oxidative stress. Transient receptor potential ankyrin 1 (TRPA1), which is activated by oxidative mediators, contributes to nociceptive signaling and neuroinflammatory processes in the relapsing–remitting experimental autoimmune encephalomyelitis (RR-EAE) model. This study investigated the effects of repeated pharmacological blockade of TRPA1 on nociceptive behaviors and disease-associated pathological mechanisms using an RR-EAE mouse model. Female C57BL/6 mice received the TRPA1 antagonist A-967079 (30 mg/kg, intragastric) from day 16 to day 36 post-induction. Behavioral, molecular, and biochemical analyses were performed. Repeated administration of A-967079 attenuated mechanical and cold allodynia without impairing locomotor function or altering body weight. TRPA1 antagonism modulated glial marker expression and plasma pro-inflammatory cytokine levels. A-967079 attenuated oxidative stress, reducing hydrogen peroxide, 4-hydroxynonenal, advanced oxidation protein product levels (TRPA1 endogenous agonists), and NADPH–cytochrome c reductase activity. These findings demonstrate that repeated TRPA1 antagonism effectively modulates neuropathic pain-like behaviors and targets key pathological mechanisms associated with RRMS. This approach closely reflects clinical management, as treatment was initiated after disease onset, when symptoms were already present. Our results support TRPA1 antagonism as a promising therapeutic strategy for pain management in RRMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPA1 Cation ChannelNociceptionEncephalomyelitis, Autoimmune, ExperimentalNeuroinflammatory DiseasesAnimalsFemaleMiceDisease Models, AnimalMice, Inbred C57BLOxidative StressNeuralgiaCytokinesHyperalgesiaOximes

Stichwörter der Autor:innen

A-967079TRP channelsallodyniaanalgesiaastrocytespain

Substanzen

TRPA1 Cation ChannelTrpa1 protein, mouseA 967079CytokinesOximes

Autor:innen und Institutionen

  • Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Santa Maria 97105-900, Brazil.
  • The Alan Edwards Centre for Research on Pain, Lyman Duff Medical Building, McGill University, Montréal, QC H3A 2B4, Canada.
  • Graduate Program in Veterinary Medicine, Federal University of Santa Maria (UFSM), Santa Maria 97105-900, Brazil.
  • Graduate Program in Biological Sciences, Federal University of Santa Maria (UFSM), Santa Maria 97105-900, Brazil.

ORCID-Profile: Ricardo Iuri Felix Moraes, Caren Antoniazzi, Helen Alves Brito, Patrícia Rodrigues, Gabriela Trevisan

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior

Zitieren

APA

Luiz, A. C. M., Peres, D. S., Kudsi, S. Q., Moraes, R. I. F., Antoniazzi, C., Pereira, L. G., Brito, H. A., Pillat, M. M., Flores, M. M., Rodrigues, P., & Trevisan, G. (2026). Repeated TRPA1 Blockade Reduces Nociception and Neuroinflammation in a Relapsing–Remitting Mouse Model of Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219592

Vancouver

Luiz ACM, Peres DS, Kudsi SQ, Moraes RIF, Antoniazzi C, Pereira LG, et al. Repeated TRPA1 Blockade Reduces Nociception and Neuroinflammation in a Relapsing–Remitting Mouse Model of Multiple Sclerosis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219592

BibTeX
@article{Luiz2026,
  author = {Luiz, Ana Clara Machado and Peres, Diulle Spat and Kudsi, Sabrina Qader and Moraes, Ricardo Iuri Felix and Antoniazzi, Caren and Pereira, Leonardo Gomes and Brito, Helen Alves and Pillat, Micheli Mainardi and Flores, Mariana Martins and Rodrigues, Patrícia and Trevisan, Gabriela},
  title = {Repeated TRPA1 Blockade Reduces Nociception and Neuroinflammation in a Relapsing–Remitting Mouse Model of Multiple Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219592}
}
Kostenlos starten →